RBGLY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Reckitt Benckiser Group PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Core Viewpoint - A class action lawsuit has been filed against Reckitt Benckiser Group PLC for alleged violations of federal securities laws related to misleading statements about the company's products and their safety [1][3]. Group 1: Lawsuit Details - The lawsuit seeks to recover damages for all individuals and entities that purchased Reckitt securities between January 13, 2021, and July 28, 2024, inclusive [2]. - The complaint alleges that Reckitt's officers made materially false and misleading statements regarding the safety of its cow's milk-based formula, Enfamil, particularly concerning the risk of necrotizing enterocolitis (NEC) in preterm infants [3]. Group 2: Next Steps for Investors - Investors who suffered losses in Reckitt have until August 4, 2025, to request to be appointed as lead plaintiff in the case [4]. - Participation in any recovery does not require serving as lead plaintiff [4]. Group 3: Legal Representation - Bronstein, Gewirtz & Grossman, LLC operates on a contingency fee basis, meaning they will only seek reimbursement for expenses and attorneys' fees if successful [5]. - The firm has a history of recovering hundreds of millions of dollars for investors in securities fraud class actions [6].